Please login to the form below

Not currently logged in
Email:
Password:

Concept Life Sciences adds to its scientific and commercial team

Dr Calvert and Dr Donaldson join the company to support growth

Michael DonaldsonConcept Life Sciences has appointed Dr Michael Donaldson (pictured right) as its principal scientist in its dermal department, a role that will see him take responsibility for its dermatology services.

With over 17 years’ experience in the pharmaceutical industry, Dr Donaldson was most recently director of biology in dermatology therapy area at GlaxoSmithKline.

Also joining the company is Dr Tim Calvert (pictured left), who becomes its vice president of business development, integrated discovery services, Europe.

Dr Calvert has experience in the delivery of integrated drug discovery and development solutions, supporting organisations ranging from virtual companies to global pharma.

Tim CalvertHe joins Concept from Aptuit, where he held various roles including senior director of integrated drug development, a role that saw him execute drug development programmes.

Philip Payne, chief commercial officer of Concept Life Sciences, said: “We are delighted to welcome both Tim and Michael to Concept.

“Their notable scientific and commercial backgrounds will be invaluable in supporting the continued expansion of the group.”

1st March 2018

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics